New perspectives for vulvodynia and chronic female pelvic pain
There are conditions that medicine still struggles to clearly define, and vulvodynia is one of them. It is a chronic pelvic floor pain, often burning and persistent, difficult to diagnose and even more difficult to treat effectively. It affects approximately one in six women, and in many cases, patients live with symptoms for years before even receiving a diagnosis.
Yet something is changing. A study published in Phytotherapy Research identified a combination of plant extracts capable of acting not only on symptoms but on the deep biological mechanisms that transform acute pain into chronic pain. The results are remarkable and worth understanding.
When conventional therapies are not enough
Those suffering from vulvodynia are familiar with the frustration of conventional treatments. Available drugs, from analgesics to neuromodulators, may offer partial relief but rarely solve the problem at its root, and often come with side effects that worsen quality of life. As a result, many women simply learn to live with the pain, giving up daily activities, relationships, and overall well-being.
The issue is not only clinical but biological. Chronic pain is not simply long-lasting pain: it is pain that the nervous system has learned to reproduce independently, even without the original trigger. Understanding this changes everything, including therapeutic approaches.
Two plants, one precise mechanism of action
Acmella oleracea is a tropical plant traditionally used for its analgesic properties. Boswellia serrata, known as Indian frankincense, is one of the most well-documented plants in literature for its ability to modulate inflammatory processes.
Individually, both show interesting effects. However, it is their combination that makes the difference.
Researchers hypothesized a synergistic effect, meaning that together they produce a greater effect than the sum of their individual actions. Preclinical models confirmed this hypothesis, opening a therapeutic scenario previously difficult to imagine in phytotherapy for chronic pain.
What happens in the central nervous system
The key finding of this research is not only pain reduction but the mechanism behind it. The study identified two main processes: neuroinflammation and spinal cord neuronal hyperactivation.
At the center are microglial cells, the immune cells of the central nervous system. Under normal conditions, they are protective. However, in chronic pain conditions, they become persistently activated and maintain a state of inflammation that keeps the nervous system in constant alert, perpetuating pain even after the original cause has disappeared.
The combination of Acmella oleracea and Boswellia serrata significantly reduced microglial activation, breaking this vicious cycle. This is not simply an analgesic effect, but an intervention on the biological basis of chronic pain itself.
A promising safety profile
One of the most interesting aspects of this research is tolerability. The plant extracts show a potentially favorable safety profile compared to conventional pharmacological options, making them suitable for long-term treatment, which is essential for chronic conditions like vulvodynia.
It is important to emphasize that these results are preclinical, obtained in animal models. Clinical trials in humans are still needed to confirm efficacy and safety in real therapeutic settings. However, the methodological strength of the study and consistency with existing literature make this a promising direction.
Why this research matters
Vulvodynia is not the only condition that could benefit from these findings. The mechanisms involved, neuroinflammation and neuronal hyperactivation, are common to many chronic pain conditions.
This means the study could open the door to new therapeutic approaches for a much broader range of conditions, with potentially significant implications for millions of patients.
If your company is interested in developing or manufacturing a product based on Acmella oleracea and Boswellia:
Source: February 2025, “Chronic pain: efficacy of phytotherapy for vulvodynia”, Integrative Medicine
